TBC1D14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.032400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.108600E-01
Normal-vs-Stage2
9.045800E-02
Normal-vs-Stage3
2.846000E-02
Normal-vs-Stage4
7.473700E-02
Stage1-vs-Stage2
2.514200E-01
Stage1-vs-Stage3
2.067500E-02
Stage1-vs-Stage4
9.989600E-02
Stage2-vs-Stage3
1.284760E-01
Stage2-vs-Stage4
4.824200E-01
Stage3-vs-Stage4
3.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.243000E-01
Normal-vs-AfricanAmerican
3.184200E-01
Normal-vs-Asian
4.791900E-02
Caucasian-vs-AfricanAmerican
7.964200E-01
Caucasian-vs-Asian
3.095000E-01
AfricanAmerican-vs-Asian
2.701200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.993350E-01
Normal-vs-Female
2.258800E-01
Male-vs-Female
3.416000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.562800E-01
Normal-vs-Age(41-60Yrs)
3.140400E-01
Normal-vs-Age(61-80Yrs)
1.784440E-01
Normal-vs-Age(81-100Yrs)
2.200000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.936000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.881400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.682400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.055700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.213800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.920440E-02
Normal-vs-Daily Drinker
8.178300E-02
Normal-vs-Weekly Drinker
5.146000E-02
Normal-vs-Occasional Drinker
3.094800E-01
Normal-vs-Social Drinker
7.503200E-01
Non Drinker-vs-Daily Drinker
4.185800E-01
Non Drinker-vs-Weekly Drinker
9.180800E-01
Non Drinker-vs-Occasional Drinker
2.106500E-02
Non Drinker-vs-Social Drinker
6.340100E-02
Daily Drinker-vs-Weekly Drinker
4.777200E-01
Daily Drinker-vs-Occasional Drinker
1.629650E-01
Daily Drinker-vs-Social Drinker
1.506620E-01
Weekly Drinker-vs-Occasional Drinker
6.203800E-02
Weekly Drinker-vs-Social Drinker
7.332500E-02
Occasional Drinker-vs-Social Drinker
5.569200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.767800E-01
Normal-vs-Grade 2
8.853400E-01
Normal-vs-Grade 3
5.571200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.719010E-01
Grade 1-vs-Grade 3
4.150000E-01
Grade 1-vs-Grade 4
5.767800E-01
Grade 2-vs-Grade 3
3.059600E-01
Grade 2-vs-Grade 4
8.853400E-01
Grade 3-vs-Grade 4
5.571200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.387900E-02
Normal-vs-NonDiabetic
2.690800E-01
Diabetic-vs-NonDiabetic
1.334210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.685800E-01
Normal-vs-NoPancreatitis
1.794990E-01
Pancreatitis-vs-NoPancreatitis
5.374600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.291400E-01
Normal-vs-N1
7.038300E-02
N0-vs-N1
1.525810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.298200E-01
Normal-vs-TP53-NonMutant
6.690200E-01
TP53-Mutant-vs-TP53-NonMutant
8.635600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
